Clinical Trial Search

Primary: To Characterize the Pharmacokinetic (PK) Profile of a Single Dose of Diclofenac Potassium Oral Solution, With Weight-based Dosing, in Pediatric Subjects, Ages 2-12 Years…

Primary: Subjective Subject Preference Survey for the First Treatment Session — 81.1; 77.6 units on a scale

Primary: Percent Change in Blood Oxygen Level Dependent (BOLD) Signal — 0.41; -0.11 percent change

Primary: Drug-related Adverse Events Consisting of Epoetin Alfa-induced Immunogenicity and Resulting Clinical Effects — 7; 0.18 percentage of participants

Primary: Area Under the Curve From Time 0 to 24 Hours of Serum LNG Concentration — 208.5; 100.8 ng*h/mL — p=<0.01

Primary: Combined Incidence of Cervical Intraepithelial Neoplasia (CIN) 2/3 or Worse Related to Human Papillomavirus (HPV) Type 6, 11, 16, or 18 — 0.0 Cases per 100 person-years…

Primary: 48 Hour Post-surgical Opioid Use — 5.32; 5.07 morphine equivalents

Primary: Hamilton Rating Scale for Depression — 25; 31 units on a scale

Primary: Percent Change From Baseline in Pain Score During Week 1 — 33.3 percent change

Primary: Change of Donor Specific Antibodies (DSA) — 35.7 percent change in DSAs

Primary: Number of Subjects With Any Grade 3 Solicited Local Symptoms — 14; 3; 14; 5 Participants

Primary: Comparison of 3 Month ODI Score Between Unipedicular and Bipedicular Kyphoplasty Groups — 15; 14 units on a scale — p=0.85

Primary: Percentage of Patients With Viral Loads < 50 Following the Switch — 20 Participants

Primary: Biologic Activity Endpoints — -3.85; -2.83; 0.05; 0.84 fold change — p=<0.05

Primary: Change From Baseline in Common Carotid Artery Intima-Media Thickness (IMT) — 0.877; 0.879; 0.036; 0.033 mm